Niclas Stiernholm
Direktor/Vorstandsmitglied bei Ontario Bioscience Industry Organization
Ursprung des Netzwerks ersten Grades von Niclas Stiernholm
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
Ontario Bioscience Industry Organization
 Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021.
14
| Non-Profit Organization | Miscellaneous Commercial Services | 14 |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada.
5
| Private Company | Pharmaceuticals: Other | 5 |
Allelix Biopharmaceuticals, Inc.
2
| Extinct | Pharmaceuticals: Major | 2 |
Tarix Pharmaceuticals Ltd.
 Tarix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Tarix Pharmaceuticals Ltd. develops peptide drugs. The private company is based in Brookline, MA. The company was founded by Joerg Gruber, Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation.
2
| Private Company | Pharmaceuticals: Major | 2 |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.
2
| Extinct | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Niclas Stiernholm
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PREMD INC. | Medical Specialties | Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| DIAMEDICA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| McGill University | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| Queen's University | College/University | Undergraduate Degree Undergraduate Degree | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| University of British Columbia | College/University | Graduate Degree | |
| University of Ottawa | College/University | Undergraduate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Masters Business Admin | |
| University of Guelph | College/University | Doctorate Degree Graduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| McMaster University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Biotechnology | Director/Board Member | |
The Canadian Institute for Advanced Research
 The Canadian Institute for Advanced Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institute for Advanced Research engages in the provision of global research networks. Its research programs include Azrieli program in brain, mind and consciousness, bio-inspired solar energy, child and brain development, cosmology and gravity, genetic networks, humans and the microbiome, institutions, organization and growth, microbial biodiversity, learning in machines and brains, quantum information science, quantum materials, and social interactions, identity and well being. The company was founded in 1981 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Chairman Chairman | |
| Medical Research Council of Canada | Corporate Officer/Principal President | ||
Advanced Technology Group USA, Inc.
 Advanced Technology Group USA, Inc. Information Technology ServicesTechnology Services Advanced Technology Group USA, Inc. provides information technology consulting services. Its services include web technology solutions, application development and maintenance, cloud computing, testing and consulting services. The company was founded in 1999 and is headquartered in Troy, MI. | Information Technology Services | Corporate Officer/Principal | |
| Richard Ivey School of Business Foundation | Corporate Officer/Principal | ||
| Wyeth Ayerst Canada, Inc. | Corporate Officer/Principal | ||
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
MedCurrent Corp.
 MedCurrent Corp. Miscellaneous Commercial ServicesCommercial Services MedCurrent Corp. provides medical appropriateness decision support technologies. The company was founded by Stephen Herman in 2004 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| PATHFINDER CELL THERAPY, INC. | Medical Specialties | Founder Chief Executive Officer | |
| The Schulich School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Richard Ivey School of Business | College/University | Masters Business Admin Masters Business Admin | |
Tarix Orphan LLC
 Tarix Orphan LLC Pharmaceuticals: MajorHealth Technology Tarix Orphan LLC is a pharmaceutical company that manufactures pharmaceutical formulation products. The private company is based in Cambridge, MA. The company was founded by Richard L. Franklin. Richard L. Franklin has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Founder | |
GeneNews (USA), Inc.
 GeneNews (USA), Inc. Medical SpecialtiesHealth Technology GeneNews (USA), Inc. operates as a cancer diagnostics company. The firm focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a primary focus on cancer-related indications. The company was incorporated on August 20, 2013 and is headquartered in Glen Allen, VA. | Medical Specialties | President | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
| Constant Therapeutics LLC | Founder Founder | ||
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Kanada | 28 |
| Vereinigte Staaten | 20 |
| Italien | 2 |
| Vereinigtes Königreich | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 11 |
| Commercial Services | 8 |
| Finance | 2 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 176 |
| Corporate Officer/Principal | 89 |
| Chairman | 68 |
| President | 54 |
| Chief Executive Officer | 49 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Calvin Stiller | 38 |
| H. Norton | 22 |
| Luke Beshar | 19 |
| Peter G. Milner | 18 |
| Meenu Chhabra Karson | 17 |
| Rick Franklin | 17 |
| Douglas A. Hamilton | 16 |
| David Allan | 16 |
| Michael G. Moore | 16 |
| Arun Menawat | 16 |
| Graham Strachan | 15 |
| Albert Agro | 13 |
| Joerg Gruber | 13 |
| James DeMesa | 13 |
| Eric Sievers | 12 |
- Börse
- Insiders
- Niclas Stiernholm
- Unternehmensverbindungen
